Qube Research & Technologies Ltd - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 179 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 1.41 and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2024$862,487
+55.5%
172,153
+141.2%
0.00%0.0%
Q3 2023$554,607
+631.7%
71,378
+306.8%
0.00%
Q4 2022$75,794
-94.5%
17,545
-84.3%
0.00%
-100.0%
Q1 2022$1,384,000111,8090.01%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2024
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 188,500$4,311,0003.12%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 334,500$7,647,0001.70%
IRONWOOD INVESTMENT MANAGEMENT LLC 131,760$3,013,0001.49%
NEA Management Company, LLC 3,069,834$70,207,0001.42%
Berry Street Capital Management LLP 575,000$13,151,0001.36%
Melqart Asset Management (UK) Ltd 916,321$20,956,0001.06%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$2,287,0000.93%
HighMark Wealth Management LLC 50,499$1,155,0000.73%
Artal Group S.A. 1,000,000$22,870,0000.62%
Vigilare Wealth Management 34,925$799,0000.47%
View complete list of AURINIA PHARMACEUTICALS INC shareholders